Yasser Khaled

695 total citations
27 papers, 385 citations indexed

About

Yasser Khaled is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Yasser Khaled has authored 27 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Yasser Khaled's work include Multiple Myeloma Research and Treatments (9 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (6 papers). Yasser Khaled is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (6 papers). Yasser Khaled collaborates with scholars based in United States, Canada and Belgium. Yasser Khaled's co-authors include Shin Mineishi, Thomas Braun, Pavan Reddy, Oleg I. Krijanovski, James L.M. Ferrara, John E. Levine, Sophie Paczesny, Carrie L. Kitko, Raymond J. Hutchinson and Sung Won Choi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Hematology.

In The Last Decade

Yasser Khaled

26 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasser Khaled United States 8 232 161 126 83 38 27 385
Kun Soo Lee South Korea 12 287 1.2× 126 0.8× 98 0.8× 70 0.8× 60 1.6× 43 449
F Baron Belgium 10 302 1.3× 191 1.2× 88 0.7× 46 0.6× 94 2.5× 17 469
Tomoyasu Jo Japan 9 113 0.5× 51 0.3× 102 0.8× 44 0.5× 26 0.7× 37 268
Hiroyuki Ohigashi Japan 9 136 0.6× 103 0.6× 75 0.6× 82 1.0× 37 1.0× 48 310
Keiko Kagami Japan 11 129 0.6× 78 0.5× 80 0.6× 130 1.6× 61 1.6× 37 379
DJ Inwards United States 8 238 1.0× 54 0.3× 110 0.9× 54 0.7× 29 0.8× 9 298
Jesse Keller United States 10 232 1.0× 62 0.4× 193 1.5× 82 1.0× 81 2.1× 21 476
Christian Duncker Germany 8 247 1.1× 141 0.9× 129 1.0× 36 0.4× 49 1.3× 8 448
S. G. Long United Kingdom 5 374 1.6× 154 1.0× 142 1.1× 27 0.3× 97 2.6× 6 461
Laura Montiel‐Cervantes Mexico 12 243 1.0× 208 1.3× 132 1.0× 102 1.2× 91 2.4× 35 469

Countries citing papers authored by Yasser Khaled

Since Specialization
Citations

This map shows the geographic impact of Yasser Khaled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasser Khaled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasser Khaled more than expected).

Fields of papers citing papers by Yasser Khaled

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasser Khaled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasser Khaled. The network helps show where Yasser Khaled may publish in the future.

Co-authorship network of co-authors of Yasser Khaled

This figure shows the co-authorship network connecting the top 25 collaborators of Yasser Khaled. A scholar is included among the top collaborators of Yasser Khaled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasser Khaled. Yasser Khaled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Khaled, Yasser, et al.. (2017). Introduction to Oral Manifestations of Systemic Diseases. Atlas of the Oral and Maxillofacial Surgery Clinics. 25(2). 85–92. 3 indexed citations
3.
Khaled, Yasser, et al.. (2016). Intraoral Pain Disorders. Oral and Maxillofacial Surgery Clinics of North America. 28(3). 275–288. 5 indexed citations
4.
Pawarode, Attaphol, Shin Mineishi, Pavan Reddy, et al.. (2015). Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series. Biology of Blood and Marrow Transplantation. 22(1). 54–60. 10 indexed citations
5.
Oyer, Jeremiah L., Robert Y. Igarashi, Dominic A. Colosimo, et al.. (2015). Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach. Biology of Blood and Marrow Transplantation. 21(4). 632–639. 62 indexed citations
6.
Khaled, Yasser, et al.. (2014). Improving Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Scores in Bone Marrow Transplant Inpatient Setting. Biology of Blood and Marrow Transplantation. 20(2). S126–S126. 3 indexed citations
7.
Nijjar, Simrit, et al.. (2013). Radiographic assessment of external root resorption associated with jackscrew-based maxillary expansion therapies: a systematic review. European Journal of Orthodontics. 36(5). 576–585. 17 indexed citations
8.
Khaled, Yasser, et al.. (2013). Plasma Cell CD20 Expression: Primary Aberrant Expression or Receptor Up-Regulation. Biology of Blood and Marrow Transplantation. 19(2). S235–S235. 2 indexed citations
11.
Ward, David, et al.. (2011). Diffuse Osteosclerosis-Associated Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(1). e3–e4. 4 indexed citations
12.
Jakubowiak, Andrzej, Tara Kendall, Ammar Al-Zoubi, et al.. (2009). Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma. Journal of Clinical Oncology. 27(30). 5015–5022. 57 indexed citations
13.
Khaled, Yasser, Pavan Reddy, & Oleg I. Krijanovski. (2009). Emerging drugs for acute graft-versus-host disease. Expert Opinion on Emerging Drugs. 14(2). 219–232. 4 indexed citations
14.
Khaled, Yasser, et al.. (2008). Incidence of hepatitis B reactivation following Rituximab therapy. American Journal of Hematology. 84(3). 195–195. 39 indexed citations
16.
Jakubowiak, Andrzej, Malathi Hari, Tara Kendall, et al.. (2008). Elimination of CD20-Expressing Cells in Multiple Myeloma by Iodine I-131 Tositumomab (Bexxar®) Correlates with Response to Therapy. Blood. 112(11). 5176–5176. 2 indexed citations
18.
Levine, John E., Sophie Paczesny, Shin Mineishi, et al.. (2007). Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood. 111(4). 2470–2475. 133 indexed citations
19.
Kato, Koji, Yasser Khaled, & Shin Mineishi. (2007). Reduced-Intensity Stem Cell Transplantation for Hematological Malignancies: Current Status and the Future. Current Stem Cell Research & Therapy. 2(2). 149–162. 6 indexed citations
20.
Jakubowiak, Andrzej, Malathi Hari, Ammar Al-Zoubi, et al.. (2007). Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).. Blood. 110(11). 4796–4796. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026